Immediate Impact
1 by Nobel laureates 4 from Science/Nature 59 standout
Citing Papers
Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Michael Stabin being referenced
Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
2000
Samarium-153-EDTMP biodistribution and dosimetry estimation.
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Stabin | 409 | 176 | 26 | 145 | 15 | 558 | |
| M.T. Hays | 426 | 148 | 9 | 85 | 13 | 607 | |
| Woutjan Branderhorst | 439 | 230 | 7 | 109 | 17 | 647 | |
| Phillips Tl | 135 | 143 | 8 | 95 | 22 | 462 | |
| D.F. Sacker | 359 | 155 | 23 | 110 | 20 | 595 | |
| Alexander Bruskin | 350 | 60 | 50 | 144 | 31 | 542 | |
| Glenda Y. Ross | 232 | 192 | 12 | 96 | 21 | 474 | |
| Gould A. Andrews | 239 | 146 | 15 | 70 | 30 | 565 | |
| Jan Wondergem | 260 | 102 | 6 | 80 | 17 | 562 | |
| Gregor J. Förster | 265 | 104 | 6 | 81 | 18 | 472 | |
| Galina Iosilevsky | 270 | 138 | 5 | 101 | 26 | 534 |
All Works
Loading papers...